▲ Peaking
Business
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.
Otsuka Receives FDA Approval for First-in-Class
1 news trends Newsylist has tracked involving Otsuka Receives FDA Approval for First-in-Class — newest first.